|
|
Volumn 27, Issue 4, 2005, Pages 493-494
|
|
Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy [2]
|
|
Author keywords
Circulating endothelial cells; Peritubular capillary flow; Transforming growth factor beta; Type 2 DM
|
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTITHROMBOCYTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
TRANSFORMING GROWTH FACTOR BETA;
VASCULOTROPIN;
VASODILATOR AGENT;
CAPILLARY FLOW;
CELL LOSS;
CIRCULATION;
DIABETIC NEPHROPATHY;
DISEASE COURSE;
EARLY DIAGNOSIS;
ENDOTHELIUM CELL;
HEMODYNAMICS;
HUMAN;
KIDNEY FUNCTION;
LETTER;
MAGNESIUM EXCRETION;
MICROALBUMINURIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RENOVASCULAR HYPERTENSION;
VASCULAR DISEASE;
VASCULAR ENDOTHELIUM;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BIOLOGICAL MARKERS;
CALCIUM CHANNEL BLOCKERS;
CASE-CONTROL STUDIES;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
ENDOTHELIAL CELLS;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
KIDNEY FUNCTION TESTS;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
VASODILATOR AGENTS;
|
|
EID: 22244476420
PISSN: 0886022X
EISSN: None
Source Type: Journal
DOI: 10.1081/JDI-65391 Document Type: Letter |
|
Times cited : (3)
|
|
References (7)
|
